High doses of nicotinamide prevent oxidative mitochondrial dysfunction in a cellular model and improve motor deficit in a Drosophila model of Parkinson's disease.
about
Drosophila melanogaster in the study of human neurodegeneration.Upregulation of GPR109A in Parkinson's diseaseNicotinamide improves motor deficits and upregulates PGC-1α and BDNF gene expression in a mouse model of Huntington's disease.α-Synuclein Transgenic Drosophila As a Model of Parkinson's Disease and Related Synucleinopathies.Using Drosophila models of neurodegenerative diseases for drug discovery.Micronutrient deficiency and cognitive and physical performance in Indian children.Nicotinamide and neurocognitive function.Exogenous nicotinamide supplementation and moderate physical exercise can attenuate the aging process in skeletal muscle of rats.The pharmacological regulation of cellular mitophagy.Metabolic Dysfunction in Parkinson's Disease: Bioenergetics, Redox Homeostasis and Central Carbon Metabolism.Variable toxicological response to the loss of OXPHOS through 1-methyl-4-phenylpyridinium-induced mitochondrial damage and anoxia in diverse neural immortal cell lines.Parp mutations protect against mitochondrial dysfunction and neurodegeneration in a PARKIN model of Parkinson's disease.Modeling Parkinson's Disease in Drosophila: What Have We Learned for Dominant Traits?Decreased NAD+ in dopaminergic neurons.
P2860
Q34022667-679D3324-09A8-4A97-AAD3-19C661B5AE7CQ34361793-DDD7CC3B-3E9A-49DC-907A-3A6D4E6942FAQ34373713-6B7052B5-DE33-4893-AB80-A42873D6939AQ34442714-D6A69EC4-EEE2-4C33-9C99-A1CFE3E042C0Q38014579-81421624-294F-472F-BABD-F51BE9A69B3AQ38081059-95834DB3-C542-4D1F-B3E6-5CD07A5F80D4Q38190088-3F9AD1BC-8E00-41B0-987A-5CF79D3DAD0AQ38801219-30007376-A01F-45CB-8667-0805C33B3367Q39095156-6F07DB38-8B1A-45B9-A702-C6E20BB5B892Q39199926-BD11B59C-5541-4CAC-94E7-9EDC068F2F24Q39713426-1283AF74-45ED-497D-B3F6-3D5BBCCFEE8DQ39947651-C7FED797-961A-49B7-B00B-871374329C04Q54114687-536C58EB-54A3-4BB3-A3C1-FFC7D22FF344Q55268885-8F2A9300-9CEA-47BF-B4F7-1CD9BDFD8EFB
P2860
High doses of nicotinamide prevent oxidative mitochondrial dysfunction in a cellular model and improve motor deficit in a Drosophila model of Parkinson's disease.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
High doses of nicotinamide pre ...... model of Parkinson's disease.
@en
High doses of nicotinamide pre ...... model of Parkinson's disease.
@nl
type
label
High doses of nicotinamide pre ...... model of Parkinson's disease.
@en
High doses of nicotinamide pre ...... model of Parkinson's disease.
@nl
prefLabel
High doses of nicotinamide pre ...... model of Parkinson's disease.
@en
High doses of nicotinamide pre ...... model of Parkinson's disease.
@nl
P2093
P356
P1476
High doses of nicotinamide pre ...... a model of Parkinson's disease
@en
P2093
Haiqun Jia
Hongxiang Gao
Jiankang Liu
P2860
P304
P356
10.1002/JNR.21650
P577
2008-07-01T00:00:00Z